Life sciences investor New Rhein announces sale of its respiratory company Softhale to Sino Biopharm ...Middle East

PHILADELPHIA and BRUSSELS, March 23, 2021 /PRNewswire/ -- New Rhein Healthcare Investors announced that it has agreed to sell its 60% stake in Softhale NV to Sino Biopharmaceutical Limited for USD 110 million upfront payment plus a profit share. The total deal value could exceed USD 200...

Hence then, the article about life sciences investor new rhein announces sale of its respiratory company softhale to sino biopharm was published today ( Tuesday 23/03/2021 - 09:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Life sciences investor New Rhein announces sale of its respiratory company Softhale to Sino Biopharm )

Also on site :

• Contractor that cut back ancient oak in London park identified
• Myanmar’s coup leader elected president by pro-military parliament
• Marks & Spencer boss warns crime is getting ‘more brazen’